Betahistine dihydrochloride quantitative determination in dosage forms by the reaction with sodium 1,2-napthoquinone-4-sulphonate
DOI:
https://doi.org/10.14739/2310-1210.2018.02.125283Keywords:
betahistine dihydrochloride, sodium 1, 2-napthoquinone-4-sulphonate, spectrophotometry, validation studiesAbstract
Objectives. Spectrophotometric method is one of the most convenient methods in pharmaceutical analysis, as it is sensitive, precise and cost effective. Therefore, the aim of the present work was the development of simple and available method for the quantitative determination of betahistine dihydrochloride in dosage forms.
Materials and methods. Sodium 1,2-napthoquinone-4-sulphonate was assessed as chemical reagent for the quantitative determination of betahistine dihydrochloride by visible spectrophotometric method.
Results. Different variables affecting the reactions between sodium 1,2-napthoquinone-4-sulphonate and the drug were carefully studied and optimized. It was established that betahistine dihydrochloride reacts with sodium 1,2-napthoquinone-4-sulphonate in alkaline medium with the colored reaction product formation with absorption maximum at 485 nm. The proposed method was subjected to validation tests. The method was validated for the parameters like linearity, precision, accuracy, robustness and scope of application. Beer’s law was obeyed over the concentration range of 2.40–4.00 mg/100 ml. Parameters of linear dependence were calculated with the help of regression analysis by means of least squares. Coefficients of stoichiometric relationship were also determined by means of molar ratios and continuous changes. The proposed procedure meets the requirements of State Pharmacopoeia of Ukraine that are made for dosage forms.
Conclusion. On the basis of the carried out investigations of betahistine dihydrochloride quantitative determination, spectrophotometric procedure has been developed and validated. This procedure is successfully applied for dosage forms analysis. Investigation results show that the procedure is highly sensitive, precise, simple in performance and relevant to be applied at the quality control laboratories for dosage forms.
References
Mashkovskij, M. D. (2012). Lekarstvennye sredstva [Drugs]. Moscow: Novaya Volna. [in Russian].
Antonenko, L. M., & Parfenov, V. A. (2017). Lekarstvennaya terapiya perifericheskogo vestibulyarnogo golovokruzheniya [Drug therapy for peripheral vestibular vertigo]. Nevrologiya, nejropsikhiatriya, psikhosomatika, 9(1), 106–110. [in Russian].
Ganjali, M., Aghili, S., Larijani, B., & Ghasemi, M. (2015). Potentiometric Determination of Betahistine in Pharmaceutical Formulations by Drug Selective Sensors. Intternational Journal of Electrochemical Science, 10, 1893–1903.
Gangrade, D., & Bakshi, S. (2014). RP-HPLC Method Development and Validation for Betahistine Hydrochloride Controlled Release Tablets. Intternational Journal of Chemical and Pharmaceutical Analysis, 2(1), 18–22.
Kalavadiya, B., Joshi, M., Makavana, K., Barochiya, K., & Kashyap, R. (2013). Development of New Method and Validation for Determination of Betahistin Dihydrochloride in Bulk and Marketed Formulation. Intternational Journal of Pharmaceutical and Chemical Sciences, 2(1), 325–334
Gangrade, D., & Bakshi, S. (2015). Dissolution Method Development Followed by Spectrophotometric Analysis and Validation of Betahistine Hydrochloride Controlled Release Tablets. Intternational Journal of Chemical and Pharmaceutical Analysis, 2(3), 168–173.
Gangrade, D., & Bakshi, S. (2014). Spectroscopic method development and validation of betahistine hydrochloride controlled release tablets. Intternational Journal of Innovative Pharmaceutical Sciences and Research, 2(10), 2369–2375.
(2015). Derzhavna Farmakopeia Ukrainy [Ukrainian Pharmacopoeia] Kharkiv: Naukovo-ekspertniy farmakopeyniy tsentr. [in Ukrainian].
Grisodub, A. I. (2016). Standartizirovannye procedury dlya proverki procedur kontrolya kachestva lekarstv [Standardized procedures for the validation of drug quality control methods]. Kharkiv. [in Russian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)